Unraveling of the innate immune system and the complement activation in FSHD cellular muscle models towards the identification of disease biomarkers

/0 Commenti/in , , , /da
Continua a leggere

Patient-derived organoids as a new in vitro paradigm to study Myotonic Dystrophy type 1

/0 Commenti/in , , , /da
Continua a leggere

Fragility fractures prevalence and bone health in a large cohort of untreated SMA patients

/0 Commenti/in , , , /da
Continua a leggere

Subjective assessment of sleep quality in adult patients with dystrophinopathy: a single centre experience.

/0 Commenti/in , , , /da
Continua a leggere

Nonsense mutations in Becker muscular dystrophy: DMD gene position and disease severity

/0 Commenti/in , , , /da
Continua a leggere

A comprehensive evaluation of mobile health technology revealed the ability to identify subtle motor impairment in patients with mild and asymptomatic Pompe disease: one-year follow-up.

/0 Commenti/in , , , /da
Continua a leggere

Kaposi’s sarcoma in myasthenia gravis patient in oral steroids treatment: two case report

/0 Commenti/in , , , /da
Continua a leggere

The hidden face of Duchenne (Neuro)Muscular Dystrophy: social cognition impairment as a feature of the neuropsychological phenotype of DMD

/0 Commenti/in , , , /da
Continua a leggere

Differences in clinical severity according to MG ADL score in patients with Myasthenia Gravis.

/0 Commenti/in , , , /da
Continua a leggere